...
首页> 外文期刊>Journal of Surgical Oncology >Extremity free fillet flap for reconstruction of massive oncologic resection—Surgical technique and outcomes
【24h】

Extremity free fillet flap for reconstruction of massive oncologic resection—Surgical technique and outcomes

机译:重建大规模肿瘤切除外科技术和结果的肢体自由圆角皮瓣

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background and Objectives The purpose of this study is to present our experience using free fillet flaps to reconstruct massive oncologic defects of the upper and lower extremity. Methods A retrospective chart review was performed to include patients who underwent oncologic resection followed by reconstruction using free fillet flaps from July 2001 to October 2018. Patient demographics, clinical and surgical characteristics, and postoperative complications were reviewed. Results In total, 12 patients were identified and included in this study. Mean age was 48.9 years old. Five patients had extended forequarter amputations and seven patients had external hemipelvectomies, all for locally advanced tumors. Mean tumor size was 15?±?SD 6.4?cm, and negative tumor margins were achieved in all the patients. Mean flap size was 1028?±?SD 869?cm 2 . The mean follow‐up was 13 months. There were no partial or total flap losses in the postoperative period. Two patients had flap‐related postoperative complications, including flap bleeding and wound dehiscence. Median survival was 18 months. Conclusion The free fillet flap is a safe, reliable, and valuable approach for reconstructing oncological defects. It offers the advantage of avoiding donor site morbidity, while providing extensive soft‐tissue coverage as a one‐step solution for massive oncologic defects.
机译:摘要背景和目标本研究的目的是展示我们使用自由圆角襟翼的经验,以重建上肢和下肢的大规模肿瘤缺陷。方法对回顾性图表审查进行了综述,包括在2001年7月至2018年7月的自由圆角襟翼重建后再进行肿瘤切除患者。审查患者人口统计,临床和外科特征以及术后并发症。结果总共鉴定了12名患者并纳入本研究。平均年龄为48.9岁。五名患者延长了前阶截肢,7名患者患有外部血管缺陷,所有患者都是局部晚期肿瘤。在所有患者中,平均肿瘤大小为15?±3.4℃,并且在所有患者中实现了阴性肿瘤余量。平均翼片尺寸为1028?±ΔSD869?CM 2。平均随访是13个月。术后期间没有部分或总皮瓣损失。两名患者患有皮瓣相关的术后并发症,包括皮瓣出血和伤口裂开。中位生存率为18个月。结论自由圆角襟翼是一种安全,可靠,有价值的方法,用于重建肿瘤缺陷。它提供了避免供体现场发病率的优势,同时提供广泛的软组织覆盖,作为大规模肿瘤缺陷的一步解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号